Safety of direct oral anticoagulants compared to warfarin in cirrhotic patients with atrial fibrillation

Background/Aims The safety of direct oral anticoagulants (DOACs) compared with warfarin in patients with both nonvalvular atrial fibrillation (AF) and clinically confirmed liver cirrhosis (LC) has not been well studied. We compared the risk of a major bleeding event between DOAC and warfarin treatme...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Seo Yeon Yoo, Eunju Kim, Gi-Byoung Nam, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee, Jonggi Choi
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Association of Internal Medicine 2022-05-01
Edice:The Korean Journal of Internal Medicine
Témata:
liver cirrhosis
atrial fibrillation
direct oral anticoagulants
warfarin
On-line přístup:http://www.kjim.org/upload/pdf/kjim-2020-622.pdf
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky